I know CRA grievances better than anyone else

CEO Kyungsun Kong Who became dreamCIS representative as a clinical expert

For CRA(Clinical Research Associate), it is very hard to communicate with many professional people.

 

It's even harder if you don't have expertise.

 

I wish my juniors would work with proud.

 

I would like to have the pride of being an expert that communicates effectively with clinical expertise, monitors clinical practice, and leads clinical practice overall.

 

Kyungsun Kong(52 years old), CEO of dreamCIS knows CRA grievances better than anyone else.

 

The core of the CRO(Clinical Research Organization) is often called CRA.

 

However, CRAs have a lot of work and are irregular, so they often move over.

 

when working as a clinical monitoring agent, you may get hurt by professional experts, such as doctors and nurses.

 

However, the power of the CRA may gaurantee clinical trial quality.

 

It's no wonder that pharmaceutical companies are rushing to many CROs with competent CRAs.

 

CEO Kong was also one of the most competent CRAs.

 

In 1995, she began to work clinical trials as a clinical nurse (CRC) at SMC.

 

The CRC is responsible for coordinating communication between subjects and researchers.

 

In 2003, she conducted clinical trials for 25 years, including Wyeth, Parexel and YUHAN.

 

She worked as a PM managing CRA at Parexel, and she took care of the clinical trial of Lasertinib, a lung cancer drug as a clinical development team leader at Yuhan.

 

CEO　Kong is probably the only one who started as a CRC and experienced various duties in the clinical field and became the head of the domestic CRO.

 

This is because most domestic CROs maintain owner representative system.

 

About the reason why she joined dreamCIS last April,“I wanted to try new experience and challenge, CEO Gong said.

 

dreamCIS is an important global CRO since it was acquired by Tigermed in China in 2015.

 

It was the first domestic CRO to undergo preliminary screening.

 

By the end of this month, it will be decided.

 

CEO Gong said, "The goal is to stably grow dreamCIS as a global CRO and It is very symbolic to have listed stocks as a leading company in the industry.

 

It is expected in many ways.“ In recent years, dreamCIS has been gradually increasing global challenges in cooperation with Tigermed.

 

20-25% of current projects are global.

 

Most of them carry out clinical tasks in China and Korea.

 

CEO　Gong said, “Chinese pharmaceutical companies are also growing so much that there is an increasing demand to conduct simultaneously clinical trials in Korea and Japan because the data is mutual recognition.” She said, "Since the merger of Taigermed, the progress of global tasks has been increasing considerably, and there are many opportunities for domestic companies to enter China." I want to contribute to the successful entry of Korean companies to China.

 

” CEO Gong plans to carry out his management philosophy with a focus on improving clinical quality.

 

She said, “The important thing is clinical quality and I pay much attention to education and talent Recruitment.” Speaking as CRO, It is the key to have good talented CRA.

 

Especially good CRAs control clinical quality.

 

More than 50% of the 200 employees are CRAs in the company, and 80% of them are women.

 

CEO Gong plans to devote herself to building a good company for women to work.“There are many benefits according to the number of women, and many of our employees are working from home and flexible, and I will continue to encourage them.” "I have experienced various companies as a female representative and also as a working mom, but I think that the diverse and flexible culture and system of dreamCIS provide more opportunities for competent working moms and young women focusing on their work creatively", she added.

 

While working as a CRA, she had a lot of hard work, but much experience brought her here with pride.

 

She advised, "To work with professionals such as nurses, pharmacists, doctors or nurses, you need expertise in the clinical field you are in charge of, and you need to communicate based on that knowledge.

 

I wish our staff, as well as juniors working in the clinical industry, would be proud to work with them.

 

” “Global CROs are starting from the CRA and going up to the country head as they build up their careers, and I also have come to this position as I build up my career from the CRAs." I think it will be a good model for new emloyees and juniors to work” she said.

 

CEO Gong concluded that she is planning a multi-faceted business after the IPO and plans to focus on a business based on the CRO.